(Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid

1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-

1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-

210644-62-5

252916-29-3

3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid

3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid

3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid

3-{2,4-Dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-yliden)methyl]-1H-pyrrol-3-yl}propansäure

3-{2,4-Dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid

5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid

9RL37ZZ665

Acide 3-{2,4-diméthyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidène)méthyl]-1H-pyrrol-3-yl}propanoïque

MFCD09743433

Orantinib

Orantinib

Orantinib

Orantinibum

(E)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid

(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid

(Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)-propionic acid

(Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid

(Z)-Orantinib

1044712-39-1

170151-24-3

1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-

1H-Pyrrole-3-propanoicacid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-

2,4-Dimethyl-5-(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl-pyrrole-3-propanoic acid

2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid

3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid

3-(2,4-dimethyl-5-((Z)-(2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid

3-(2,4-DIMETHYL-5-{[(3Z)-2-OXO-1H-INDOL-3-YLIDENE]METHYL}-1H-PYRROL-3-YL)PROPANOIC ACID

3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone

3-[2,4-Dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]-propionic acid

3-[2,4-dimethyl-5-[(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid

3-[2,4-dimethyl-5-[(2-oxo-3-indolinylidene)methyl]-1H-pyrrol-3-yl]propanoic acid

3-[2,4-dimethyl-5-[(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid

3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid

3-[2,4-dimethyl-5-[(z)-(2-oxo-1h-indol-3-ylidene)methyl]-1h-pyrrol-3-yl]propanoicacid

3-[2,4-dimethyl-5-[(Z)-(2-oxo-3-indolinylidene)methyl]-1H-pyrrol-3-yl]propanoic acid

3-[2,4-dimethyl-5-[(Z)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid

3-[5-[(2-ketoindolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl]propionic acid

3-[5-[(Z)-(2-ketoindolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl]propionic acid

3-{2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid

3-{2,4-Dimethyl-5-[2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-1H-pyrrol-3-yl}-propionic acid

5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid

5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid

5-[(z)-(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-propanoic acid

EGFR_HUMAN

Epidermal growth factor receptor

FGFR1_HUMAN

Fibroblast growth factor receptor 1

MFCD03426212

Orantinib (SU6668)

orantinib (tsu-68)

orantinib (tsu-68, su6668)

orantinibum

PDGFR Tyrosine Kinase Inhibitor VI, SU6668

Pdgfr tyrosine kinase inhibitor vi,su6668

PGFRB_HUMAN

SU 6668;TSU68;TSU 68;SU6668

TSU-68 (Random Configuration)

Tsu-68 (su6668, orantinib)

TSU-68 (SU6668,Orantinib)

tsu68(su6668,orantinib)

VGFR2_HUMAN

орантиниб

أورانتينيب